Missouri Vly Cancer Consortium Omaha, NE - 68106

Missouri Vly Cancer Consortium is categorized under Research Institute in Omaha, NE and active since 2004.

Missouri Vly Cancer Consortium was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Research Institute business, which does work in the B2B market, and is classified as a Research Institute, under code number 5417115 by the NAICS.

If you are seeking more information, feel free to contact Mary Beth Wilwerding, Director at the company’s single location by writing to 6818 Grover St Floor 4th, Omaha, Nebraska NE 68106 or by phoning (402) 991-8070. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Missouri Vly Cancer Consortium
Contact Person: Mary Beth Wilwerding, Director
Address: 6818 Grover St Floor 4th, Omaha, Nebraska 68106
Phone Number: (402) 991-8070
Website Address: aboutmvcc.org
Annual Revenue (USD): Unknown
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research Institute
SIC Code: 8733
NAICS Code: 5417115
Share This Business:

Missouri Vly Cancer Consortium was started in 2004 to provide professional Research Institute under the SIC code 8733 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Mary Beth Wilwerding, Director for inquiries that concern Missouri Vly Cancer Consortium by calling the company number (402) 991-8070, as your correspondence is most welcome. Additionally, the physical location of the single location of Missouri Vly Cancer Consortium can be found at the coordinates 41.22707,-96.01863 as well as the street address 6818 Grover St Floor 4th in Omaha, Nebraska 68106.

For its online presence, you may visit Missouri Vly Cancer Consortium’s website at aboutmvcc.org and engage with its social media outlets through on Twitter and on Facebook.